It was the Amy V Show

[anonymous]

Think twice before you rip about Biogen-your ceo came from there-and thankfully is righting this bloated ship called Genentech

Anderson joined Genentech in 2006. Prior to Genentech, Anderson was Vice President of the Neurology Business Unit at Biogen Idec. Before that, Anderson was Biogen’s Vice President of Finance with oversight of global planning, budgeting and deal evaluations. In this role he led the financial integration of Biogen and Idec Pharmaceuticals. He earlier held the role of Country Head for Biogen’s United Kingdom & Ireland operations.

All the more reason why he should understand.

 

[anonymous]

Yeah Im sure Genentech is scared lol. Come on Ocrevus is the best drug and doesn't take a lot of selling. With or without us its going to grow and be a monster. Its the best drug and less expensive. Case closed. Not saying we didnt get the train rolling but not that it is reps are needed as much. As time goes by docs have drug Rx experience and tell other docs. Stop fooling yourself, come on

You’re probably the biggest idiot ever to post anything on CF. Your own words will someday will be your demise. You idiot.

 

[anonymous]

Genentech doesn’t know what they are doing in the MS space. We just put a billion dollars in the bank with the launch of a total game changer in Ocrevus. The train is just now beginning to roll with the community guys and gals. The timing of this ridiculous “transformation” will harm bottom line sales of Ocrevus. The momentum we started will now grind to a halt as we all wait and see what is going to happen in July. Obviously they are hoping for attrition, and I guarantee you they will get it. The MS Reps that came over to this cluster were top performers at their previous companies. Most felt we would get at least 5 solid years to make Ocrevus the go to med. If Genentech burns these reps, trust me, they will also pay a price in losing a lot of Ocrevus Sales when the Neurologists learn to hate Genentech just like the Oncologists and Hospitals do. Most in this division are friends with their customers and trust me friendship trumps Genentech Marketing. Tread lightly Bill...

 

[anonymous]

Nope: You keep your buddy buddy relationships. You give me some PRO reps who look for solutions and not excuses....You would have seen the General Neuro business move forward already.

 

[anonymous]

Hard to qualify that Gene doesnt know the MS business after the most successful drug launches ever in industry, right? See I have facts you have opinions and its facts that matter. Gene went into a market they weren't in prior to Ocrevus ,against many competitors , and have performed beyond expectations.

 

[anonymous]

Hard to qualify that Gene doesnt know the MS business after the most successful drug launches ever in industry, right? See I have facts you have opinions and its facts that matter. Gene went into a market they weren't in prior to Ocrevus ,against many competitors , and have performed beyond expectations.

You might be right, however let’s unpack this. You’re no longer valued or needed. Hope you didn’t buy into that “family” bs.
Ocrevus will be just fine without you. Good luck in the mid year transformation. You’ll need it.

 

[anonymous]

Hey at least you made $40k per qtr right? It was a fun ride and like all good things, they come to an end. We were way over paid anyway, making huge bonuses selling a drug that was less expensive and superior dosing and efficacy. Dont pay yourself on the back for selling alcohol to an alcoholic Lets keep it realz, ok?

 

[anonymous]

Hey at least you made $40k per qtr right? It was a fun ride and like all good things, they come to an end. We were way over paid anyway, making huge bonuses selling a drug that was less expensive and superior dosing and efficacy. Dont pay yourself on the back for selling alcohol to an alcoholic Lets keep it realz, ok?

This is a bunch of crap and an attempt to railroad this thread. You are neither a rep for this franchise and probably not a rep at all. Go Fck yourself. Seriously. If your thinking that kind of money was accurate, you’re wrong, if you’re also thinking that is a high amount, there are companies that pay way more during launches. You are ignorant.

The bottom line is Genentech needs to be loyal to its employees.

 

[anonymous]

We really don't deserve that plan bonus as it was easy sell. Now the gravy train is over and I'm moving on.

 

[anonymous]

We really don't deserve that plan bonus as it was easy sell. Now the gravy train is over and I'm moving on.

Keep it up fire starter. You are pathetic. The only thing I can tell you is this. Karma is a real bitch. It might not be now. It might not be 6 months from now, but you will get yours. You have intentionally put these comments in to induce panic and a lot of negativity. Whether you want to acknowledge it or not, there ar many innocent people that work very hard here. The bonuses are average for a launch so let’s not blow this out of proportion. These people have families and mortgages to pay. You’re a real mother fkr and your statements are flat out lies. If this drug was an easy sell, everyone would be using it. It’s a constant struggle every day, especially with the sub par services. You are the lowest ass of the Earth and you can go to hell. So you either are a bad egg from another franchise, another company, a sorry excuse who went for this job and was turned down, or just an ass. Which one is it?

 

[anonymous]

Reps are paid too much for these position. It's hard to imaging how the "Ivy League" upper management does not understand supply and demand.

 

[anonymous]

Keep it up fire starter. You are pathetic. The only thing I can tell you is this. Karma is a real bitch. It might not be now. It might not be 6 months from now, but you will get yours. You have intentionally put these comments in to induce panic and a lot of negativity. Whether you want to acknowledge it or not, there ar many innocent people that work very hard here. The bonuses are average for a launch so let’s not blow this out of proportion. These people have families and mortgages to pay. You’re a real mother fkr and your statements are flat out lies. If this drug was an easy sell, everyone would be using it. It’s a constant struggle every day, especially with the sub par services. You are the lowest ass of the Earth and you can go to hell. So you either are a bad egg from another franchise, another company, a sorry excuse who went for this job and was turned down, or just an ass. Which one is it?

I did get mine, and it was a beautiful Rolex watch thank you. Next time you interview and are offered another job ask for the " loyalty pledge" since all companies should be loyal to their employees, lol. Ocrevus is a great drug, no? If so then you have an edge in selling it, right? So stop making it like you're selling a dog product, and Access Solutions is the best in industry, and stop blaming our partners, albeit it not perfect but def best ive seen

 

[anonymous]

I did get mine, and it was a beautiful Rolex watch thank you. Next time you interview and are offered another job ask for the " loyalty pledge" since all companies should be loyal to their employees, lol. Ocrevus is a great drug, no? If so then you have an edge in selling it, right? So stop making it like you're selling a dog product, and Access Solutions is the best in industry, and stop blaming our partners, albeit it not perfect but def best ive seen

Lol omg you sound like a moron. Best in industry? You are so naive it’s silly. How old are you? Thank you for giving so many people a great laugh tonight. Enjoy that Rolex kid and keep on kissing ass.

 

[anonymous]

I did get mine, and it was a beautiful Rolex watch thank you. Next time you interview and are offered another job ask for the " loyalty pledge" since all companies should be loyal to their employees, lol. Ocrevus is a great drug, no? If so then you have an edge in selling it, right? So stop making it like you're selling a dog product, and Access Solutions is the best in industry, and stop blaming our partners, albeit it not perfect but def best ive seen

Not sure how you got a Rolex since Sales Consistency is 3 out of 5 years Sales Excellence? The franchise has only been in existence for a year.

 

[anonymous]

Yeah Im sure Genentech is scared lol. Come on Ocrevus is the best drug and doesn't take a lot of selling. With or without us its going to grow and be a monster. Its the best drug and less expensive. Case closed. Not saying we didnt get the train rolling but not that it is reps are needed as much. As time goes by docs have drug Rx experience and tell other docs. Stop fooling yourself, come on

Total affirmation that Genentech doesn’t understand the MS Market. Obviously written by a Genentech Legacy with limited understanding of the Neurology space.

Ocrevus is a great drug, but in this crowded market if you don’t think it requires selling you are a total fool. Genentech needs as many folks on the ground as possible to counter detail the Biogen and Novartis Reps. Is Ocrevus the “best drug”? I could make a strong case for both Tysabri and Gilenya. If you think Neurologists believe it is the “best drug” we would have cornered the market. There are still many concerns in Neurology and it’s obvious you don’t understand your customers. Yes I believe it is, but I’m not writing prescriptions...wake up dufus. “Less Expensive”? Actually this isn’t true due to contracting, something Genentech doesn’t know how to do. The above posts absolutely clarifies why it is important to have tenured MS Reps in the field. Once again Genentech misses the target and doesn’t understand the market. If you leave this to the San Fran talking heads and ivy league analytics you will create a disaster with this promising treatment. If I were calling the shots I wouldn’t touch the Ocrevus franchise right now, especially if it causes disruption during the continued launch.

 

[anonymous]

Total affirmation that Genentech doesn’t understand the MS Market. Obviously written by a Genentech Legacy with limited understanding of the Neurology space.

Ocrevus is a great drug, but in this crowded market if you don’t think it requires selling you are a total fool. Genentech needs as many folks on the ground as possible to counter detail the Biogen and Novartis Reps. Is Ocrevus the “best drug”? I could make a strong case for both Tysabri and Gilenya. If you think Neurologists believe it is the “best drug” we would have cornered the market. There are still many concerns in Neurology and it’s obvious you don’t understand your customers. Yes I believe it is, but I’m not writing prescriptions...wake up dufus. “Less Expensive”? Actually this isn’t true due to contracting, something Genentech doesn’t know how to do. The above posts absolutely clarifies why it is important to have tenured MS Reps in the field. Once again Genentech misses the target and doesn’t understand the market. If you leave this to the San Fran talking heads and ivy league analytics you will create a disaster with this promising treatment. If I were calling the shots I wouldn’t touch the Ocrevus franchise right now, especially if it causes disruption during the continued launch.

Yeah. Sure. Bio onc peeps been saying that for years. One day they looked up and were shown the door. You’re just another number, bub.

 

[anonymous]

Did Mgmt say how many were getting cut? No one seems to know what transformation means. The MCCO all hands meetings talked like this but without details. I sense a huge cut coming

 

[anonymous]

Did Mgmt say how many were getting cut? No one seems to know what transformation means. The MCCO all hands meetings talked like this but without details. I sense a huge cut coming

Like all of GNE - get off the ship while you still can. Sorry it happened so soon after you joined the company but it's been coming for years. Don't invest too much here...

 

[anonymous]

How come there is an attempt to bury this thread at the bottom? Truth hurt?

 

[anonymous]

Bio-similars, no new products on the horizon, and Gene being killed in the oncology market by Merck, Bristol, etc is where we are today. Gene used to be the premier oncology Co and now struggles against traditional big pharma companies. This Co. is nothing special and will struggle for years to come